EDI Spotlight: Madhav Swaminathan, MD
In this month’s EDI Spotlight, Madhav Swaminathan, MD shares how he became involved with a group focused on increasing inclusion of neurodiversity, a disability that he says is often hidden yet deserves more attention in EDI work.
MaryAnn Black Symposium Centers Health Equity in 2nd Annual Community Event
As part of the university's centennial celebration, the Duke Cancer Institute hosted the 2nd annual MaryAnn Black Distinguished Health Equity Symposium in honor of the late MaryAnn Black.
Centennial Spotlights Mary Duke Biddle Trent Semans
A principal link in the life of this university.” That is how former Duke University President Richard H. Broadhead described Mary Duke Biddle Trent Semans.
Research Triangle Universities Team Up to Unravel Cellular Mysteries
Duke University, in collaboration with the University of North Carolina-Chapel Hill and NC State University, has received a three-year, $3 million grant from the Chan Zuckerberg Initiative (
Duke-NCCU Partnership Honored with NIH Prize for Excellence in Diversity and Research
Duke University and North Carolina Central University recently received the National Institutes of Health (NIH) Institutional Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) in
Surviving Gun Violence
Duke University Hospital focuses on an often-overlooked issue in gun violence: creating a path forward for gunshot wound survivors.
No Matter Where They Live Women are Less Likely to Get Bystander CPR
Women are less likely than men to receive life-saving CPR and defibrillator help during cardiac arrest – a problem that persists regardless of neighborhood diversity.
Centennial Spotlights Robert Califf
An internationally recognized expert in cardiovascular medicine, health outcomes research, health care quality, and clinical research, Dr. Robert Califf now heads the U.S. Food and Drug Administration.
Centennial Trailblazer: Joseph W. Turek
Duke’s chief of pediatric cardiac surgery, Dr. Joseph W. Turek, has built his career on repairing the defective or damaged hearts of the very youngest patients, while continually looking for ways to make their care better.
Tumor Biology May Underlie Racial Differences in Certain Breast Cancer Outcomes
Regardless of socioeconomic factors and tumor variables, Black women with triple negative breast cancer have a significantly poorer response to chemotherapy than white women, researchers at Duke Cancer Institute report.